Frequency of Hepatocellular Carcinoma in Patients with Non-Cirrhotic Liver: A Cross-Sectional Study of Liver Findings on Triphasic CT Scan

Authors

  • Ghazal Tasleem Diagnostic Radiology, Chughtai Lab Lahore
  • Furqan Ahmad Chugtai Lab, Lahore
  • Muhammad Mubeen Ul Haq
  • Maryam Irfan

DOI:

https://doi.org/10.37018/ZCQK2238

Keywords:

Hepatocellular carcinoma, computed tomography, liver cancer, liver diseases.

Abstract

Background: Hepatocellular carcinoma (HCC) can arise in both cirrhotic and non-cirrhotic livers. In non-cirrhotic liver, diagnosis may be challenging because non-invasive imaging criteria have limitations, and histopathological confirmation may be required when guideline-based imaging criteria are not applicable. Triphasic CT provides multiphasic assessment of hepatic lesions and background liver morphology. Local data regarding HCC in patients without radiological cirrhosis are limited. This study aimed to determine the frequency of non-cirrhotic liver among patients with HCC evaluated by triphasic CT and compare selected clinical and radiological characteristics between cirrhotic and non-cirrhotic groups.
Methodology: This cross-sectional study included 116 adults aged 18–70 years referred for triphasic CT evaluation of suspicious hepatic nodule(s). Patients were consecutively enrolled during the study period September 1st 2025 to March 1st 2026, from the referral population of Chughtai Lab, Lahore. No histopathological confirmation was reported in the submitted study dataset. Cirrhosis was classified radiologically using periportal space and caudate-to-right-lobe ratio measurements. Demographic, clinical, and CT variables were recorded and analyzed using descriptive statistics and Pearson chi-square tests.
Results: Of 116 patients with HCC, 37 (31.9%) were classified as having non-cirrhotic and 79 (68.1%) as having cirrhotic liver morphology on triphasic CT. The mean age was 52.27 ± 10.50 years, and 86 (74.1%) patients were male. HCV infection was present in 52 (44.8%), HBV infection in 29 (25.0%), diabetes mellitus in 48 (41.4%), hypertension in 37 (31.9%), and smoking in 45 (38.8%). Mean lesion size was 4.94 ± 2.56 cm; 51 (44.0%) had lesions >5 cm and 82 (70.7%) had right-lobe involvement. No statistically significant associations were observed between radiological cirrhosis status and the assessed clinical or radiological variables (all p>0.05). Statistically significant differences in periportal space and caudate-to-right-lobe ratio measurements reflected the predefined radiological classification criteria for cirrhosis.
Conclusion: Consideration of HCC in patients without radiological cirrhosis and careful multiphasic CT assessment is important, particularly when conventional imaging criteria for HCC diagnosis may not be applicable.  Further studies with histopathological correlation and broader populations are warranted.

References

1. Konyn P, Ahmed A, Kim D. Current epidemiology in hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol. 2021;15(11):1295-1307. doi:10.1080/17474124.2021.1991792.

2. Sharma R. Descriptive epidemiology of incidence and mortality of primary liver cancer in 185 countries: evidence from GLOBOCAN 2018. Jpn J Clin Oncol. 2020;50(12):1370-1379.

doi:10.1093/jjco/hyaa130.

3. Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6. doi:10.1038/s41572-020-00240-3.

4. Desai A, Sandhu S, Lai JP, Sandhu DS. Hepatocellular carcinoma in non-cirrhotic liver: a comprehensive review. World J Hepatol. 2019;11(1):1-18. doi:10.4254/wjh.v11.i1.1.

5. Lee DH, Lee JM. Primary malignant tumours in the non-cirrhotic liver. Eur J Radiol. 2017;95:349-361. doi:10.1016/j.ejrad.2017.08.030.

6. Engstrand J, Stål P, Gilg S, Jansson A, Strömberg C. Hepatocellular carcinoma in cirrhotic versus non-cirrhotic liver: treatment and survival differences in a nationwide cohort. Scand J Surg. 2024;113(2):120-130. doi:10.1177/14574969231220179.

7. Moctezuma-Velázquez C, Lewis S, Lee K, Amodeo S, Llovet JM, Schwartz M, et al. Non-invasive imaging criteria for the diagnosis of hepatocellular carcinoma in non-cirrhotic patients with chronic hepatitis B. JHEP Rep. 2021;3(6):100364.

doi:10.1016/j.jhepr.2021.100364.

8. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma. J Hepatol. 2025;82(2):315-374. doi:10.1016/j.jhep.2024.08.028.

9. Butt AK, Khan AA, Alam A, Ahmad S, Shah SW, Shafqat F, et al. Hepatocellular carcinoma: analysis of 76 cases. J Pak Med Assoc. 1998;48(7):197-201.

10. Vogel A, Chan SL, Dawson LA, Kelley RK, Llovet JM, Meyer T, et al. Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2025;36(5):491-506.

doi:10.1016/j.annonc.2025.02.006.

11. Gong W, Gong S, Chang H, Ma C, Zhao Q, Zhou X, et al. Optimising contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS) for hepatocellular carcinoma diagnosis in non-cirrhotic hepatitis B virus infection patients: incorporating alpha-fetoprotein or adjusting washout criteria. Clin Radiol. 2026;96:107292. doi:10.1016/j.crad.2026.107292.

12. Catucci D, Hrycyk J, Lange NF, Obmann VC, Berzigotti A, Brönnimann MP, et al. Liver segmental volumes and their relationship with 5-year prognostication. Abdom Radiol (NY). 2025;50(3):1133-1142.

doi:10.1007/s00261-024-04552-w.

13. Biondetti P, Bruno A, Brancatelli G, et al. Liver remodeling on CT examination in patients with HCV compensated cirrhosis who achieved sustained virological response after direct-acting antivirals treatment. J Clin Med. 2020;9(4):1100. doi:10.3390/jcm9041100.

14. Sattar A, Rasheed B, Farhan N, Hafeez M, Mughal S. Morphologic abnormalities of diffuse liver diseases at triphasic CT exam. Rawal Med J. 2021;46(4):765-769.

Downloads

Published

16.11.2026

How to Cite

1.
Tasleem G, Ahmad F, Muhammad Mubeen Ul Haq, Irfan M. Frequency of Hepatocellular Carcinoma in Patients with Non-Cirrhotic Liver: A Cross-Sectional Study of Liver Findings on Triphasic CT Scan . J Fatima Jinnah Med Univ [Internet]. 2026 Nov. 16 [cited 2026 Nov. 17];20(3):136-40. Available from: https://jfjmu.com/index.php/ojs/article/view/1557